Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v3.22.1
Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash $ 19,743,096 $ 27,204,269
Acquired patents, net 11,712 12,615
Total assets 19,754,808 27,216,884
Current liabilities    
Accounts payable & accrued interest 220,845 220,845
Unreimbursed expenses 20,323 164,327
Total current liabilities 241,168 385,172
Total liabilities 241,168 385,172
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,951,453 and 13,147,829 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 12,952 13,148
Additional paid-in capital 55,117,845 60,466,093
Accumulated deficit (35,617,157) (33,647,529)
Total stockholders’ equity 19,513,640 26,831,712
Total liabilities and stockholders’ equity $ 19,754,808 $ 27,216,884